Company: BOLT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058632
Chunk: 8

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 8
---
 without instructions on non-routine matters, and therefore there may be broker non-votes on Proposal 1. Proposals 2 (the ratification of the selection by the audit committee of PricewaterhouseCoopers LLP, as our independent registered public accounting firm for the year ending December 31, 2025) and 3 (the approval of an amendment to our certificate of incorporation to effect a reverse stock split of

<div align='center'>3</div>

our issued and outstanding common stock) are considered routine under applicable rules. A broker or other nominee may generally vote on routine matters, and therefore no broker non-votes are expected to exist in connection with Proposals 2 or 3.

How are votes counted?

Votes will be counted by the inspector of election appointed for the Annual Meeting, who will count:

With respect to Proposal 1, “For” votes and “Withhold” votes, and broker non-votes.

With respect to Proposal 2, “For” votes, “Against” votes and abstentions.

With respect to Proposal 3, “For” votes, “Against” votes and abstentions.

Abstentions will be counted towards the vote total for Proposal 2 and will have the same effect as “Against” votes. Abstentions will not be counted and will have no effect on the vote total for Proposal 3. Proposals 2 and 3 are each considered a “routine” matter, accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank, or other agent that holds your shares, your broker, bank, or other agent has discretionary authority to vote your shares on Proposals 2 and 3.

Who will serve as inspector of elections?

Sarah Nemec, our Senior Vice President, Finance, will serve as the inspector of elections.

How many votes are needed to approve each proposal?

For Proposal 1 electing two members of the Board, our bylaws provide for a plurality voting standard for the election of directors. Under this voting standard, the two director nominees receiving the highest number of affirmative votes will be elected as Class I directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.

For Proposal 2 ratifying the audit committee’s selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025, the proposal must receive a “For” vote from the majority of the votes